title: Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage.
abstract: BACKGROUND
  Intracerebral hemorrhage (ICH) constitutes 10% to 15% of all strokes. Despite several existing outcome prediction models for ICH, there are some factors with equivocal value as well as others that still have not been evaluated.
  
  
  METHODS
  All patients with first ever supratentorial ICH presenting to our institution between December 1995 and December 2002 were prospectively enrolled into the study. Patients with historic modified Rankin Scale > 2 and those under anticoagulant treatment or with multiple ICH were excluded. The following parameters were analyzed in 194 consecutive patients: age, gender, past history of hypertension, diabetes mellitus, hypercholesterolemia, past history of ischemic stroke, presence of ischemic heart disease or cardioembolic disease, current antiplatelet treatment, current alcohol overuse, smoking, Glasgow Coma Scale score (GSS) at admission, volume and location (deep or lobar) of ICH, ventricular extension, glycemia and temperature at admission, and leukoaraiosis. We correlated these data with the 30-day mortality identifying the independent predictors by logistic regression analysis.
  
  
  RESULTS
  Factors independently associated with 30-day mortality were: age, Glasgow Coma Scale score at admission, ICH volume, ventricular extension, glucose level at admission, and previous antiplatelet use.
  
  
  CONCLUSIONS
  Apart from the classical outcome predictors, the previous use of antiplatelet agents and the glucose value at admission are independent predictors of 30-day mortality in patients suffering a supratentorial ICH.
authors.affiliation: Unitat d'Ictus, Servei de Neurología, Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, Spain. 35826@imas.imim.es
authors.forename: Jaume
authors.initials: J
authors.lastname: Roquer
authors.forename: Ana
authors.initials: A
authors.lastname: Rodríguez Campello
authors.forename: Meritxell
authors.initials: M
authors.lastname: Gomis
authors.forename: Angel
authors.initials: A
authors.lastname: Ois
authors.forename: Victor
authors.initials: V
authors.lastname: Puente
authors.forename: Elvira
authors.initials: E
authors.lastname: Munteis
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002543:Cerebral Hemorrhage / Q000188:drug therapy* / Q000401:mortality*; D005260:Female; D005500:Follow-Up Studies; D005544:Forecasting; D015600:Glasgow Coma Scale; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D016015:Logistic Models; D008297:Male; D017063:Outcome Assessment, Health Care / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012189:Retrospective Studies; D012720:Severity of Illness Index
chemical_list: D010975:Platelet Aggregation Inhibitors; D005947:Glucose
references.citation: Neurology. 2000 Jun 27;54(12):2298-301
references.pmid: 10881256
references.citation: Stroke. 2000 Nov;31(11):2558-62
references.pmid: 11062275
references.citation: J Neurol. 2002 Dec;249(12):1704-9
references.pmid: 12529793
references.citation: Diabetes Care. 2000 Oct;23(10):1527-32
references.pmid: 11023147
references.citation: Stroke. 2001 Feb;32(2):438-41
references.pmid: 11157179
references.citation: Stroke. 2003 Apr;34(4):840-8
references.pmid: 12649515
references.citation: Cerebrovasc Dis. 2001;11(3):195-200
references.pmid: 11306767
references.citation: Stroke. 2003 Feb;34(2):387-91
references.pmid: 12574547
references.citation: Stroke. 1991 May;22(5):571-6
references.pmid: 2028484
references.citation: Acta Neurol Scand. 1997 Sep;96(3):174-82
references.pmid: 9300072
references.citation: J Neurol Sci. 1999 Jul 1;166(2):107-14
references.pmid: 10475103
references.citation: Stroke. 1998 May;29(5):887-94
references.pmid: 9596230
references.citation: Arch Neurol. 1995 Dec;52(12):1193-200
references.pmid: 7492294
references.citation: JAMA. 1998 Dec 9;280(22):1930-5
references.pmid: 9851479
references.citation: Stroke. 1997 Jun;28(6):1185-8
references.pmid: 9183348
references.citation: Stroke. 2003 Jul;34(7):1717-22
references.pmid: 12805488
references.citation: Stroke. 2003 May;34(5):1151-5
references.pmid: 12663877
references.citation: J Neurosurg. 2002 Sep;97(3):531-6
references.pmid: 12296635
references.citation: Crit Care Med. 1999 Mar;27(3):617-21
references.pmid: 10199544
references.citation: Cerebrovasc Dis. 1999 Jan-Feb;9(1):10-21
references.pmid: 9873158
references.citation: Stroke. 2001 Apr;32(4):891-7
references.pmid: 11283388
references.citation: Stroke. 1998 Jun;29(6):1160-6
references.pmid: 9626289
references.citation: Stroke. 2001 Feb;32(2):399-404
references.pmid: 11157173
references.citation: Stroke. 1988 Feb;19(2):192-5
references.pmid: 3344534
references.citation: Stroke. 1995 Oct;26(10 ):1764-7
references.pmid: 7570722
references.citation: Eur Neurol. 2000;43(4):209-14
references.pmid: 10828650
references.citation: J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):653-7
references.pmid: 1527534
references.citation: Neurol Res. 2000 Dec;22(8):791-6
references.pmid: 11149240
references.citation: Neurology. 2000 Oct 10;55(7):947-51
references.pmid: 11061249
references.citation: Stroke. 1991 Jan;22(1):1-6
references.pmid: 1987664
references.citation: Stroke. 1997 Jul;28(7):1396-400
references.pmid: 9227690
references.citation: Stroke. 1996 Aug;27(8):1304-5
references.pmid: 8711791
references.citation: Stroke. 1995 Dec;26(12 ):2249-53
references.pmid: 7491645
references.citation: Stroke. 1993 Jul;24(7):987-93
references.pmid: 8322400